ARAY vs TMO · rev $401.9M vs P/E 24, rev $23.00B
Accuray Incorporated (ARAY) versus Thermo Fisher Scientific Inc (TMO) — a side-by-side from cached financials, not a winner call.
Accuray Incorporated (ARAY) is a medical devices company listed on US.
Thermo Fisher Scientific Inc (TMO) is a diagnostics & research company listed on US.
Latest reported ARAY revenue for 2026-06-30 was $401.9M. Net income was -$49.2M. Revenue was down 12.3% from 2025-06-30 to 2026-06-30. ARAY currently screens at market cap $140.1M.
Latest reported TMO revenue for 2026-06-27 was $23.00B. Net income was $3.39B. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
ARAY currently screens at market cap $140.1M. TMO currently screens at market cap $153.06B and trailing P/E 23.8.
Not investment advice. Open the ARAY and TMO stock pages for the full models.
Not investment advice.